Concomitant prescribing of benzodiazepines during antidepressant therapy in the elderly

Journal of Clinical Epidemiology

Volumn 55, Issue 10, 2002, Pages 1049-1053

  Van Dijk, K N ^a,b   De Vries, C S ^c   Ter Huurne, K ^a   Van den Berg, P B ^a   Brouwers, J R B J ^a   De Jong van den Berg, L T W ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b MEDICAL CENTER LEEUWARDEN   (Netherlands)

^c UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Antidepressants; Anxiolytics; Benzodiazepines; Elderly; Hypnotics; Prescribing

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; HYPNOTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ZOLPIDEM; ZOPICLONE;

ADULT; AGED; ANTICHOLINERGIC EFFECT; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEPRESSION; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG USE; EXTRAPYRAMIDAL SYMPTOM; FALLING; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INSOMNIA; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPOTENSION; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL;

AGED; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BENZODIAZEPINES; DEPRESSION; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FOLLOW-UP STUDIES; HUMANS;

EID: 0036818796     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(02)00457-2     Document Type: Article

References (24)

1. Avorn J., Gurwitz J.H. Drug use in the nursing home. Ann Intern Med. 123:1995;203-211.
2. Flint A.J. Choosing appropriate antidepressant therapy in the elderly. A risk-benefit assessment of available agents. Drugs Aging. 13:1998;269-280.
3. Mamdani M.M., Parikh S.V., Austin P.C., Upshur R.E. Use of antidepressants among elderly subjects. trends and contributing factors Am J Psychiatry. 157:2000;360-367.
4. Salzman C. Practical considerations for the treatment of depression in elderly and very elderly long-term care patients. J Clin Psychiatry. 60(Suppl 20):1999;30-33.
5. Pollock B.G. Adverse reactions of antidepressants in elderly patients. J Clin Psychiatry. 60(Suppl 20):1999;4-8.
6. Mittmann N., Herrmann N., Einarson T.R., Busto U.E., Lanctot K.L., Liu B.A., Shulman K.I., Silver I.L., Narango C.A., Shear N.H. The efficacy, safety and tolerability of antidepressants in late life depression. a meta-analysis J Affect Disord. 46:1997;191-217.
7. Williams J.W., Mulrow C.D., Chiquette E., Hitchcock Noël P., Aguilar C., Cornell J. A systematic review of newer pharmacotherapies for depression in adults. evidence report summary Ann Intern Med. 132:2000;743-756.
8. Steffens D.C., Krishnan K.B., Helms M.J. Are SSRIs better than TCAs? Comparison of SSRIs and TCAs. a meta-analysis Depress Anxiety. 6:1997;10-18.
9. Thapa P.B., Gideon P., Cost T.W., Milam A.B., Ray W.A. Antidepressants and risk of falls among nursing home residents. N Engl J Med. 339:1998;875-882.
10. Liu B., Anderson G., Mittman N., To T., Axcell T., Shear N. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet. 351:1998;1303-1307.
11. Parkes A. Starting SSRI antidepressant therapy. its effect on tricyclic antidepressant and benzodiazepine prescribing (letter) Med J Aust. 164:1996;509.
12. Rascati K. Drug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with anxiety/sleep medications. Clin Ther. 17:1995;786-790.
13. Gregor K., Riley J., Downing D. Concomitant use of anxiolytics and hypnotics with selective serotonin reuptake inhibitors. Clin Ther. 18:1996;521-527.
14. Bingefors K., Isacson D.G.L. Concomitant prescribing of tranquilizers and hypnotics among patients receiving antidepressant prescriptions. Ann Pharmacother. 32:1998;531-535.
15. Pathiyal A., Hylan T.R., Jones J.K., Davtian D., Sverdlov L., Keyser M. Prescribing of selective serotonin reuptake inhibitors, anxiolytics, and sedative-hypnotics by general practitioners in the Netherlands. a multivariate analysis Clin Ther. 19:1997;798-810.
16. Joffe R.T., Levitt A.J., Sokolov S.T.H. Augmentation strategies. focus on anxiolytics J Clin Psychiatry. 57(Suppl 7):1996;25-31.
17. Holbrook A.M., Crowther R., Lotter A., Cheng C., King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ. 162:2000;225-233.
18. Ray W.A., Thapa P.B., Gideon P. Benzodiazepines and the risk of falling in nursing home residents. J Am Geriatr Soc. 48:2000;682-685.
19. Hanlon J.T., Horner R.D., Schmader K.E., Fillenbaum G.G., Lewis I.K., Wall W.E., Landerman L.R., Pieper C.F., Blazer D.G., Cohen H.J. Benzodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Ther. 64:1998;684-692.
20. Tobi H., Van den Berg P.B., De Jong-van den Berg L.T.W. The InterAction database. synergy of science and practice in pharmacy Brause R.W., Hanisch E. Medical data analysis. first international symposium; proceedings/ISMDA:2000;206-211 Springer; Berlin.
21. Lau H.S., de Boer A., Beuning K.S., Porsius A. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol. 50:1997;619-625.
22. Anonymous Anatomical therapeutical chemical (ATC) classification index including defined daily dosages (DDDs) for plain substances. 2000;World Health Organisation Collaborating Centre for Drug Statistics Methodology; Oslo.
23. Dutch Health Council Towards a more appropriate use of benzodiazepines. Publication number 1998/20. 1998;Health Council; The Hague.
24. Anderson I.M. Selective serotonin reuptake inhibitors versus tricyclic antidepressants. a meta-analysis of efficacy and tolerability J Affect Disord. 58:2000;19-36.